- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rituximab (mabthera) Injection
Total 12761 results
-
Helse FonnaCompletedAutoimmune Hemolytic Anemia | Cold Agglutinin DiseaseFinland, Denmark, Norway
-
Institute of Hematology & Blood Diseases Hospital...RecruitingPlatelet Transfusion Refractoriness | Severe Aplastic AnemiaChina
-
PfizerCompletedFollicular LymphomaUnited States, Spain, United Kingdom, Korea, Republic of, France, Portugal, India, Mexico, Switzerland, Japan, Germany, Romania, Greece, Austria, Belgium, Italy, Thailand, Croatia, Philippines, Russian Federation, Puerto Rico, Ukr... and more
-
French Innovative Leukemia OrganisationLymphoma Study AssociationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Shandong UniversityThe Affiliated Hospital of Qingdao University; Yantai Yuhuangding HospitalUnknownPurpura, Thrombocytopenic, Idiopathic | Immune ThrombocytopeniaChina
-
University Hospital, RouenNot yet recruitingPemphigus | Dermatologic Disease
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
Haukeland University HospitalOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsActive, not recruitingRelapsing Remitting Multiple SclerosisNorway, Sweden
-
JHL Biotech, Inc.TerminatedArthritis, Rheumatoid | Rheumatoid ArthritisBosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Lithuania, Poland, Russian Federation, Taiwan, Ukraine, United Kingdom
-
Nantes University HospitalHoffmann-La Roche; French Innovative Leukemia OrganisationCompletedB-Cell LymphomaFrance
-
SecuraBioTerminatedFollicular LymphomaFrance, Italy, Australia, Poland
-
Hopital FochMinistry of Health, FranceRecruiting
-
Newcastle-upon-Tyne Hospitals NHS TrustNewcastle University; National Institute for Health Research, United Kingdom; Department of Health, United KingdomCompletedFatigue | Primary Biliary CirrhosisUnited Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Hoffmann-La RocheBiogenCompletedRheumatoid ArthritisBelgium, Germany, Norway, United Kingdom, United States, Ireland, France, Canada, Israel, Netherlands, Italy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Medical University of ViennaRecruitingMantle-cell LymphomaAustria
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruiting
-
Hoffmann-La RocheNordic Lymphoma GroupCompleted
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicAustralia, Brazil, Spain, Italy, Canada, Germany, Chile, Mexico, France, Argentina, Croatia, Russian Federation, Slovakia, Turkey, Poland, Czechia, New Zealand, Portugal, Greece
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicFinland, France, Spain, Portugal, Turkey, United Kingdom, Sweden, Tunisia
-
Dana-Farber Cancer InstituteHiberCell, Inc.CompletedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomasUnited States
-
Fudan UniversityTerminated
-
Hoffmann-La RocheCompleted
-
Chinese University of Hong KongCompleted
-
Fredrik PiehlUnknownA Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis (Rinomax)Generalized Myasthenia GravisSweden
-
Ranjana AdvaniGenentech, Inc.CompletedLymphoma | Hodgkin Lymphoma (Category) | Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
MEI Pharma, Inc.Kyowa Kirin, Inc.Withdrawn
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
German Low Grade Lymphoma Study GroupTerminatedIndolent LymphomaGermany
-
Copenhagen University Hospital at HerlevCompletedPrednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic AnemiaAnemia, Hemolytic, AutoimmuneDenmark
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Vivozon, Inc.CompletedPost-Operative PainKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupCompletedEosinophilic Granulomatosis With Polyangiitis (EGPA)France
-
Asociacion Espanola de Hematologia y HemoterapiaCompleted
-
Ohio State University Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Hoffmann-La RocheCompleted
-
Shanghai Henlius BiotechActive, not recruiting
-
Mabscale, LLCRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHairy Cell Leukemia | Recurrent Hairy Cell LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann... and other conditionsUnited States